Archive for September, 2009
New treatments for methicillin-resistant Staphylococcus aureus
Methicillin-resistant Staphylococcus aureus (MRSA) is a dynamic pathogen. Rates of MRSA are increasing worldwide. In some centers, MRSA is becoming less susceptible to vancomycin, and these strains have been associated with worse clinical outcomes. Intermediate or fully resistant vancomycin strains of MRSA have emerged clinically, whereas MRSA acquired in the community has become epidemic.
read more
Survival of Staphylococcus and other bacteria in skin prick test antigens solutions
Skin prick tests are commonly used for human allergy testing and determination. Because solutions are kept at 4°C and patient’s skin is cleaned, the same solutions are used on many patients with the same applicators without sterilization. read more
